Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Genet Mol Res ; 11(1): 725-30, 2012 Mar 22.
Artigo em Inglês | MEDLINE | ID: mdl-22576830

RESUMO

A number of studies have pointed to the association of BDNF (brain-derived neurotrophic factor) and DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, 32 kDa) with schizophrenia. The purpose of this study was to determine whether these two genes are involved in the pathogenesis of schizophrenia in the Malay population. Two single nucleotide polymorphisms Val66Met of BDNF, -2036C>G and g.1238delG of DARPP-32 were genotyped in the Malay population in 200 patients with schizophrenia and 256 healthy controls. Analysis of allele and genotype frequencies in these two groups revealed no significant association of BDNF or DARPP-32 polymorphisms with schizophrenia in Malays. This is the first such association study in the Malay population.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/genética , Fosfoproteína 32 Regulada por cAMP e Dopamina/genética , Esquizofrenia/genética , Adulto , Alelos , Povo Asiático/genética , Feminino , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Humanos , Malásia , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Fatores de Risco
2.
Immunopharmacology ; 24(1): 1-10, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1333454

RESUMO

In this study, we examined the effect of TNFa on bradykinin (BK) B2 receptor binding and function in human A431 epidermoid carcinoma cells. [3H]BK binds to a single class of receptors on A431 cells in a saturable and reversible manner. A binding affinity (KD) of 3.0 +/- 0.3 nM (n = 4) and a Bmax of 151 +/- 14 fmols/10(6) cells, representing approximately 90,000 BK receptors per cell, was observed. The rank order of potency for BK agonist peptides indicates that the A431 BK receptor appears to be of the B2 subtype. When A431 cells were incubated with TNFa (10 ng/ml) for 48 h prior to BK binding, a significant decrease in the number of BK receptors compared to control was observed. TNFa did not influence the affinity of BK binding to A431 cells and direct addition of TNFa to the binding assay did not effect BK binding. BK-stimulated IP1 formation appeared to be increased in TNFa treated cells compared to control whereas histamine-stimulated IP1 formation was not influenced. Both control and TNFa treated cells were greater than 95% viable. However, TNFa treated cells were blocked in the G1 phase of the cell cycle resulting in a decrease in DNA synthesis. This may be one mechanism for the TNFa-induced decrease in BK receptors in A431 cells.


Assuntos
Bradicinina/metabolismo , Carcinoma de Células Escamosas/patologia , Fosfatidilinositóis/metabolismo , Receptores de Neurotransmissores/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologia , Carcinoma de Células Escamosas/metabolismo , Divisão Celular/efeitos dos fármacos , Humanos , Receptores da Bradicinina , Receptores de Neurotransmissores/metabolismo , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA